Yondelis (trabectedin, ET-743) is a novel antitumor agent derived from a marine source, the Caribbean tunicate Ecteinascidia turbinata. Used for the treatment of patients with liposarcoma or leiomyosarcoma.
As an art director at Publicis Health Spain, I created a visual campaign to communicate the effectiveness of this medicine when it is applied in the right order.